chronic heart failure

Zensun Announces Ph II Results For Neucardin™ Heart Failure Drug

Zensun Sci & Tech, Ltd. announced Thursday positive results of four completed Phase II clinical trials for its anti-heart failure drug, Neucardin™.

SciClone Licenses Chronic Heart Failure Drug From Zensun

SciClone Pharma has licensed from Zensun (Shanghai) Science & Technology Co. Ltd. its chronic heart failure drug, Neucardin.